Please login to the form below

Not currently logged in


This page shows the latest Combioxin news and features for those working in and with pharma, biotech and healthcare.

Non-antibiotic could ‘transform pneumonia therapy’

Non-antibiotic could ‘transform pneumonia therapy’

Lancet hails study as medical breakthrough. Swiss biotech Combioxin has published the first clinical data on a new way to treat serious infections, by neutralising toxins made by pathogens. ... Combioxin is now planning a new study that will test CAL02

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...